Cargando…

Thrombosis and Anticoagulation Strategies in Patients with COVID-19 Including Japanese Perspective

Coronavirus disease 2019 (COVID-19) has become a major health problem worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory infectious disease, it could also cause cardiovascular complications, including thrombosis. Thus, anticoagulation therapy has been thought to hel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Yugo, Kobayashi, Takao, Mo, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067339/ https://www.ncbi.nlm.nih.gov/pubmed/36792179 http://dx.doi.org/10.5551/jat.RV22002

Ejemplares similares

The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
por: Nishimoto, Yuji, et al.
Publicado: (2022)

The Primary Prevention of Venous Thromboembolism in Patients with COVID-19 in Japan: Current Status and Future Perspective
por: Yamashita, Yugo, et al.
Publicado: (2021)

A case of a systemic cancer-associated thrombosis successfully treated with multi-disciplinary treatment including anticoagulation therapy and anticancer drug therapy
por: Yoneda, Fumiya, et al.
Publicado: (2023)

Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study
por: Yamashita, Yugo, et al.
Publicado: (2022)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population
por: Poh, Kai Chin, et al.
Publicado: (2020)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)

Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID study
por: Ogihara, Yoshito, et al.
Publicado: (2023)

Risk Factors and Impact on Outcomes of Thrombosis in Patients with COVID-19 in Japan: From the CLOT-COVID Study
por: Yachi, Sen, et al.
Publicado: (2023)

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
por: Warrior, Surbhi, et al.
Publicado: (2020)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study
por: Yamashita, Yugo, et al.
Publicado: (2023)

Clinical Features Comparing Arterial Thrombosis and Venous Thromboembolism in Hospitalized Patients with COVID-19: Result from the CLOT-COVID Study
por: Umetsu, Michihisa, et al.
Publicado: (2023)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Development of Arterial Thrombosis in a Patient on Therapeutic Anticoagulation for COVID-19
por: Nagori, Essam K, et al.
Publicado: (2021)

Acute Peripheral Arterial Thrombosis in COVID-19 Patients on Therapeutic Anticoagulation
por: Kumar, Abhyuday, et al.
Publicado: (2021)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

Anticoagulant Therapy in Thrombosis
por: Jorpes, J. Erik
Publicado: (1946)

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19
por: Voicu, Sebastian, et al.
Publicado: (2021)

Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review
por: Niculae, Cristian-Mihail, et al.
Publicado: (2023)

Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism　― Insights From the J’xactly Study ―
por: Yamashita, Takeshi, et al.
Publicado: (2022)

Anticoagulation in COVID-19: DDI Perspective
por: Khiali, Sajad, et al.
Publicado: (2020)

Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus
por: Yuan, Wenjun, et al.
Publicado: (2022)

Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease
por: Abdelghani, Eman, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population
por: Lim, Hui Yin, et al.
Publicado: (2016)

Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan: From the CLOT-COVID Study
por: Hayashi, Hiroya, et al.
Publicado: (2022)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

The Need to Anticoagulate Patients With Splenic Vein Thrombosis
por: Benjamin, Clara, et al.
Publicado: (2022)

Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury
por: Wang, Chengyue, et al.
Publicado: (2022)

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
por: Basili, Stefania, et al.
Publicado: (2018)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.
por: Klein, David E., et al.
Publicado: (2020)

Thrombosis and Anticoagulation in East Asian Patients With COVID-19: Another Phenotype of “East Asian Paradox”
por: Ki, You-Jeong, et al.
Publicado: (2022)

Ascending aorta thrombosis in a patient with COVID-19 who was already receiving anticoagulation therapy
por: Bouratzis, Vasileios, et al.
Publicado: (2023)

Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection
por: Naser, Jwan A, et al.
Publicado: (2021)

Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19
por: Cullivan, S., et al.
Publicado: (2022)

Coagulation and anticoagulation in COVID-19
por: Hadid, Tarik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3euh3uf5d87no3pp2gl5ndgrmr